On June 1, 2026, Biohaven Ltd. (NYSE:BHVN) announced the initiation of first-in-human dosing for BHV-8100, its oral, ...

Regenerative Peptides can be helpful in treating symptoms of fatigue, low energy, slow injury recovery, poor muscle ...

Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, June 5, 2026-Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage ...

Edgewise Therapeutics (EWTX) stays a Buy after its $2.65B Servier deal funds EDG-7500 for HCM with key Q2 2026 data. Read ...

Veru to Conduct Enobosarm Clinical Study With Novo Nordisk's Weight-Loss Pill Wegovy Veru agreed to conduct a clinical study of one of its treatments in combination with Novo Nordisk's Wegovy weight ...

Veru Inc. (NASDAQ:VERU) has entered into a clinical supply agreement with Novo Nordisk A/S (NYSE:NVO) to support its upcoming ...

Discussion highlights growing importance on novel ADC payloads, and Akari’s ASCO data in KRAS-driven cancers and future potential. Access the Akari CEO Corner here. TAMPA, Fla.

Our Phase 2 design reflects both the translational science and the realities of ALS by integrating validated biomarkers such as neurofilament light chain alongside clinically meaningful endpoints,” ...

Open-back headphones aren't known for thunderous low-end. But Audeze thinks it's found a fix ...

Elevate your mix with the Audeze MM-520 studio headphones. Designed with Manny Marroquin, these next-gen cans deliver pro-level precision. Upgrade your sound.

Audeze has announced the release of the MM-520, the newest addition to its Manny Marroquin Signature Series of professional studio headphones. Designed as the next evolution of the acclaimed MM-500, ...

Researchers from Ospedale San Raffaele presented the preclinical characterization of SR-1891, a long-acting capsid assembly modulator (CAM) in models of chronic hepatitis B. In Hepa D38 cells, the ...